Comvita Limited has swung back to profitability in FY26, reporting $7.7 million net profit after a $40.5 million capital raise that brought Southeast Asian consumer giant F&N Ventures on board with a near 20% stake.
- FY26 revenue up 10.7% to $213 million
- Net profit after tax of $7.7 million
- Net cash position achieved, net debt reduced from $62.4 million
- Strategic investor F&N Ventures acquires 19.99% stake
- Operational improvements and market diversification underpin results
Profitability Restored Amid Market Challenges
After years of financial strain, New Zealand’s Comvita Limited (NZX:CVT) has delivered a marked turnaround in FY26, posting a net profit after tax (NPAT) of $7.7 million against a loss of $104.8 million the previous year. Revenue climbed 10.7% to $213 million, driven largely by strong volume growth in North America and steady performance in Southeast Asia and Europe, offsetting softness in Greater China and Australia/New Zealand.
The operating profit before financing costs jumped to $14 million from a $29 million loss in FY25, reflecting disciplined cost control, improved manufacturing efficiencies, and a leaner operating model. Operating cash flow rose to $40.3 million, enabling the company to reduce net debt by nearly $63 million to a net cash position of $0.5 million by June 2026.
Capital Raise and Strategic Partnership with F&N Ventures
Central to Comvita’s financial reset was a $40.5 million capital raise completed in May 2026, comprising a $30 million pro-rata Rights Offer and a $10.5 million strategic placement to F&N Ventures Pte. Ltd., a subsidiary of Singapore-listed Fraser and Neave, Limited. This transaction introduced F&N as a near 20% shareholder, marking a significant milestone in Comvita’s growth ambitions across Southeast Asia.
The capital injection allowed Comvita to repay existing bank debt and secure new refinancing facilities with Westpac and ANZ extending to September 2028. The strengthened balance sheet provides the company with the flexibility to invest selectively in brand, science, and innovation while maintaining financial discipline.
F&N’s entry is expected to accelerate Comvita’s expansion in ASEAN markets through enhanced distribution, innovation, and local market insights. Early collaboration efforts are focused on aligning strategies to create mutual value in the region.
Market Diversification and Operational Improvements
Comvita’s revenue mix shifted notably in FY26, with North America’s share surging to 27.6%, more than doubling from 14.9% in FY25. This growth was powered by an expanded club-retail partnership and new grocery listings, which also aided inventory normalisation and manufacturing utilisation.
Greater China, while still the largest market at 34.5% of revenue, faced headwinds from cautious consumer spending and increased price competition, leading to a 4.7% sales decline and a 12.1% drop in profit. Despite this, Comvita maintained its leadership position with over 50% market share and strengthened online sales by bringing e-commerce in-house.
Rest of Asia markets, particularly Singapore and Korea, posted strong double-digit sales growth and improved profitability through strategic retail optimisation and digital channel expansion. Europe and the Middle East returned to profitability, benefiting from a distributor-led model and new partnerships, including a key pharmacy retailer in Saudi Arabia.
Innovation and Science-Led Differentiation
Comvita continues to leverage its science-backed Mānuka honey products as a competitive advantage. The company highlighted progress in its Lepteridine™ research, a unique compound linked to gut health, with plans to initiate the largest clinical trial of Mānuka honey in the US in FY27. This research underpins product innovation and premium positioning, expanding the brand beyond traditional honey offerings.
Product innovation in FY26 included the launch of new Mānuka honey lozenge flavours and eye health capsules, reinforcing Comvita’s strategy to diversify and elevate its product portfolio. Investments in digital capabilities and e-commerce platforms, including a pilot TikTok Shop in the US, are also underway to capture evolving consumer trends.
Sustainability and Governance
Comvita’s FY26 Annual Report underscores its commitment to environmental stewardship and social responsibility. The company manages climate-related risks through diversified supply chains and sustainable Mānuka forest planting programs, which also contribute to carbon sequestration and biodiversity.
Governance enhancements included board refreshment with new directors bringing expertise in Asian markets and consumer goods. The leadership team was substantially rebuilt to align with the company’s strategic priorities. Comvita maintained robust financial controls and compliance, with audited financial statements and independent assurance on greenhouse gas emissions reporting.
Looking Ahead
With its balance sheet repaired and operational foundations strengthened, Comvita enters FY27 focused on improving operating leverage, expanding earnings sources, and investing selectively in brand and innovation. The company acknowledges ongoing challenges, including geopolitical tensions, pricing pressures, and variable honey harvests, but is optimistic about leveraging its unique assets and strategic partnerships to drive sustainable growth.
The market will be watching how Comvita capitalises on F&N’s regional expertise and whether its innovation pipeline and operational efficiencies translate into consistent profit growth amid a complex global landscape.
Bottom Line?
Comvita’s FY26 turnaround sets the stage for disciplined growth, but execution risks and market volatility remain key challenges.
Questions in the middle?
- How will F&N Ventures’ strategic involvement influence Comvita’s Southeast Asian expansion plans?
- Can Comvita sustain profitability while navigating pricing pressures and category commoditisation in Greater China?
- What impact will the upcoming large-scale clinical trial have on Comvita’s product innovation and market positioning?